Advanced search
Publication Cover
Molecular and Cellular Biology Volume 27, 2007 - Issue 22
Submit an article Journal homepage
9
Views
52
CrossRef citations to date
0
Altmetric
Article

Epigenetic Control of the Immune Escape Mechanisms in Malignant Carcinomas

A. Francesca Setiadi1 Biomedical Research Centre, Vancouver, British ColumbiaV6T 1Z3, Canada;2 Michael Smith Laboratories, Vancouver, British ColumbiaV6T 1Z4, Canada;3 Department of Zoology, University of British Columbia, Vancouver, British ColumbiaV6T 1Z4, Canada
,
Muriel D. David1 Biomedical Research Centre, Vancouver, British ColumbiaV6T 1Z3, Canada
,
Robyn P. Seipp1 Biomedical Research Centre, Vancouver, British ColumbiaV6T 1Z3, Canada;2 Michael Smith Laboratories, Vancouver, British ColumbiaV6T 1Z4, Canada;3 Department of Zoology, University of British Columbia, Vancouver, British ColumbiaV6T 1Z4, Canada
,
Jennifer A. Hartikainen1 Biomedical Research Centre, Vancouver, British ColumbiaV6T 1Z3, Canada;2 Michael Smith Laboratories, Vancouver, British ColumbiaV6T 1Z4, Canada;5 Department of Microbiology and Immunology, University of British Columbia, Vancouver, British ColumbiaV6T 1Z3, Canada
,
Rayshad Gopaul2 Michael Smith Laboratories, Vancouver, British ColumbiaV6T 1Z4, Canada
&
Wilfred A. Jefferies1 Biomedical Research Centre, Vancouver, British ColumbiaV6T 1Z3, Canada;2 Michael Smith Laboratories, Vancouver, British ColumbiaV6T 1Z4, Canada;3 Department of Zoology, University of British Columbia, Vancouver, British ColumbiaV6T 1Z4, Canada;4 Department of Medical Genetics, University of British Columbia, Vancouver, British ColumbiaV6T 1Z3, Canada;5 Department of Microbiology and Immunology, University of British Columbia, Vancouver, British ColumbiaV6T 1Z3, CanadaCorrespondence[email protected]
Pages 7886-7894 | Received 23 Aug 2007, Accepted 30 Aug 2007, Published online: 27 Mar 2023

Citations (52)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marijana Nesic, Tarec Christoffer El-Galaly, Martin Bøgsted, Inge Søkilde Pedersen & Karen Dybkær. (2020) Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma. Expert Review of Hematology 13:6, pages 655-668.
Read now

Articles from other publishers (51)

Lilian L. Nohara, Samantha L. S. Ellis, Carola Dreier, Sarah Dada, Iryna Saranchova, Lonna Munro, Cheryl G. Pfeifer, Krysta M. Coyle, Jessica R. Morrice, Daniel Joo Sung Shim, Paul Ahn, Nicole De Voogd, David E. Williams, Ping Cheng, Emmanuel Garrovillas, Raymond J. Andersen & Wilfred A. Jefferies. (2023) A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours. Frontiers in Pharmacology 14.
Crossref
Dawn Sijin Nin & Lih-Wen Deng. (2023) Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer. Cells 12:6, pages 926.
Crossref
Nhat-Chau TRUONG, Nhi-Thao HUYNH, Kmuong-Duy PHAM & Phuc-Van PHAM. (2023) Roles of cancer stem cells in cancer immune surveillance. Minerva Biotechnology and Biomolecular Research 35:1.
Crossref
Sarah Dada, Samantha L. S. Ellis, Christi Wood, Lilian L. Nohara, Carola Dreier, Nicolas H. Garcia, Iryna Saranchova, Lonna Munro, Cheryl G. Pfeifer, Brett A. Eyford, Suresh Kari, Emmanuel Garrovillas, Giorgia Caspani, Eliana Al Haddad, Patrick W. Gray, Tunc Morova, Nathan A. Lack, Raymond J. Andersen, Larry Tjoelker & Wilfred A. Jefferies. (2023) Specific cannabinoids revive adaptive immunity by reversing immune evasion mechanisms in metastatic tumours. Frontiers in Immunology 13.
Crossref
Amanda L. Johnson, John Laterra & Hernando Lopez-Bertoni. (2022) Exploring glioblastoma stem cell heterogeneity: Immune microenvironment modulation and therapeutic opportunities. Frontiers in Oncology 12.
Crossref
Sina Taefehshokr, Aram Parhizkar, Shima Hayati, Morteza Mousapour, Amin Mahmoudpour, Liliane Eleid, Dara Rahmanpour, Sahand Fattahi, Hadi Shabani & Nima Taefehshokr. (2022) Cancer immunotherapy: Challenges and limitations. Pathology - Research and Practice 229, pages 153723.
Crossref
Adviti Naik, Remy Thomas, Ghaneya Al‐Khadairi, Rim Bacha, Wouter Hendrickx & Julie Decock. (2021) Cancer testis antigen PRAME: An anti‐cancer target with immunomodulatory potential. Journal of Cellular and Molecular Medicine 25:22, pages 10376-10388.
Crossref
M.L.M. Jongsma, J. Neefjes & R.M. Spaapen. (2021) Playing hide and seek: Tumor cells in control of MHC class I antigen presentation. Molecular Immunology 136, pages 36-44.
Crossref
Fang Wang, Greg Malnassy & Wei Qiu. (2021) The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Xun-Rui Chen, Hai-Hua Yuan, Jia-Hui Guo, Wen-Ying Zhang, Qian-Qian Li, Guo-Ding Huang, Yan-Jie Zhang, Bin Jiang & Feng Liu. (2020) A signal peptide derived from Hsp60 induces protective cytotoxic T lymphocyte immunity against lymphoid malignancies independently of TAP and classical MHC-I. Cancer Letters 494, pages 47-57.
Crossref
Elena Maryamchik, Kathleen Mary Ellen Gallagher, Frederic I. Preffer, Stephan Kadauke & Marcela V. Maus. (2020) New directions in chimeric antigen receptor T cell [CAR‐T] therapy and related flow cytometry. Cytometry Part B: Clinical Cytometry 98:4, pages 299-327.
Crossref
Wei Yang, Yanyan Li, Ruoling Gao, Zenghe Xiu & Ting Sun. (2019) MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway. Oncogene 39:5, pages 1098-1111.
Crossref
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, Roberta Visconti, Aniello Cerrato & Angela Celetti. (2019) New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Marine Leclerc, Laura Mezquita, Guillaume Guillebot De Nerville, Isabelle Tihy, Ines Malenica, Salem Chouaib & Fathia Mami-Chouaib. (2019) Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing. Frontiers in Immunology 10.
Crossref
Kevin Dzobo. (2019) Epigenomics-Guided Drug Development: Recent Advances in Solving the Cancer Treatment “jigsaw puzzle”. OMICS: A Journal of Integrative Biology 23:2, pages 70-85.
Crossref
Karim Vermaelen. (2019) Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses. Frontiers in Immunology 10.
Crossref
David J. Zahavi & Louis M. Weiner. 2019. Cancer Immunotherapy. Cancer Immunotherapy 61 100 .
Aurélie Durgeau, Yasemin Virk, Gwendoline Gros, Elodie Voilin, Stéphanie Corgnac, Fayçal Djenidi, Jérôme Salmon, Julien Adam, Vincent de Montpréville, Pierre Validire, Soldano Ferrone, Salem Chouaib, Alexander Eggermont, Jean-Charles Soria, François Lemonnier, Eric Tartour, Nathalie Chaput, Benjamin Besse & Fathia Mami-Chouaib. (2018) Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours. Nature Communications 9:1.
Crossref
Natalia Arenas-Ramirez, Dilara Sahin & Onur Boyman. (2018) Epigenetic mechanisms of tumor resistance to immunotherapy. Cellular and Molecular Life Sciences 75:22, pages 4163-4176.
Crossref
Koen A. Marijt, Laura Blijleven, Els M.E. Verdegaal, Michel G. Kester, Daniel J. Kowalewski, Hans-Georg Rammensee, Stefan Stevanović, Mirjam H.M. Heemskerk, Sjoerd H. van der Burg & Thorbald van Hall. (2018) Identification of non-mutated neoantigens presented by TAP-deficient tumors. Journal of Experimental Medicine 215:9, pages 2325-2337.
Crossref
Jyothishmathi Swaminathan & Vidya Gopalakrishnan. 2018. Immunotherapy in Translational Cancer Research. Immunotherapy in Translational Cancer Research 143 160 .
Iryna Saranchova, Jeffrey Han, Rysa Zaman, Hitesh Arora, Hui Huang, Franz Fenninger, Kyung Bok Choi, Lonna Munro, Cheryl G. Pfeifer, Ian Welch, Fumio Takei & Wilfred A. Jefferies. (2018) Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis. Scientific Reports 8:1.
Crossref
Irina Daniela Florea & Christina Karaoulani. 2018. Cancer Epigenetics for Precision Medicine. Cancer Epigenetics for Precision Medicine 203 218 .
Andrea M. Henle, Aziza Nassar, Danell Puglisi-Knutson, Bahaaeldin Youssef & Keith L. Knutson. (2017) Downregulation of TAP1 and TAP2 in early stage breast cancer. PLOS ONE 12:11, pages e0187323.
Crossref
Sophia Xiao Pfister & Alan Ashworth. (2017) Marked for death: targeting epigenetic changes in cancer. Nature Reviews Drug Discovery 16:4, pages 241-263.
Crossref
Man Liu, Jingying Zhou, Zhiwei Chen & Alfred Sze-Lok Cheng. (2017) Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy. The Journal of Pathology 241:1, pages 10-24.
Crossref
Iryna Saranchova, Jeffrey Han, Hui Huang, Franz Fenninger, Kyung Bok Choi, Lonna Munro, Cheryl Pfeifer, Ian Welch, Alexander W. Wyatt, Ladan Fazli, Martin E. Gleave & Wilfred A. Jefferies. (2016) Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33. Scientific Reports 6:1.
Crossref
Erika Héninger, Timothy E. G. Krueger & Joshua M. Lang. (2015) Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents. Frontiers in Immunology 6.
Crossref
Veronika Vlková, Ivan Štěpánek, Veronika Hrušková, Filip Šenigl, Veronika Mayerová, Martin Šrámek, Jana Šímová, Jana Bieblová, Marie Indrová, Tomáš Hejhal, Nicolas Dérian, David Klatzmann, Adrien Six & Milan Reiniš. (2014) Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes. Oncotarget 5:16, pages 6923-6935.
Crossref
Luca Sigalotti, Elisabetta Fratta, Sandra Coral & Michele Maio. (2014) Epigenetic drugs as immunomodulators for combination therapies in solid tumors. Pharmacology & Therapeutics 142:3, pages 339-350.
Crossref
David Kosoff, Timothy Krueger & Joshua M Lang. (2013) Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies. Immunotherapy 5:11, pages 1243-1254.
Crossref
Hannah V. Siddle & Jim Kaufman. (2013) A tale of two tumours: Comparison of the immune escape strategies of contagious cancers. Molecular Immunology 55:2, pages 190-193.
Crossref
Tamal Das & Suman Chakraborty. (2013) Perspective: Flicking with flow: Can microfluidics revolutionize the cancer research?. Biomicrofluidics 7:1.
Crossref
Tao Qiu, Lei Wang, Xiu-heng Liu, Xiao-dong Weng, You-lin Kuang, Zhi-yuan Chen, Hui Chen & Heng-cheng Zhu. (2012) Over-expressing transporters associated with antigen processing increases antitumor immunity response in prostate cancer. Cellular Immunology 279:2, pages 167-173.
Crossref
Irene Romero, Marisol Martinez, Cristina Garrido, Antonia Collado, Ignacio Algarra, Federico Garrido & Angel M Garcia-Lora. (2012) The tumour suppressor Fhit positively regulates MHC class I expression on cancer cells. The Journal of Pathology 227:3, pages 367-379.
Crossref
Barbara Seliger. (2011) Novel insights into the molecular mechanisms of HLA class I abnormalities. Cancer Immunology, Immunotherapy 61:2, pages 249-254.
Crossref
Aurélie Durgeau, Faten El Hage, Isabelle Vergnon, Pierre Validire, Vincent de Montpréville, Benjamin Besse, Jean-Charles Soria, Thorbald van Hall & Fathia Mami-Chouaib. (2011) Different Expression Levels of the TAP Peptide Transporter Lead to Recognition of Different Antigenic Peptides by Tumor-Specific CTL. The Journal of Immunology 187:11, pages 5532-5539.
Crossref
J Šímová, V Polláková, M Indrová, R Mikyšková, J Bieblová, I Štěpánek, J Bubeník & M Reiniš. (2011) Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status. British Journal of Cancer 105:10, pages 1533-1541.
Crossref
Min Ji Seo, Gi Rak Kim, Young Min Son, Deok-Chun Yang, Hyuk Chu, Tae Sun Min, In Duk Jung, Yeong-Min Park, Seung Hyun Han & Cheol-Heui Yun. (2011) Interactions of dendritic cells with cancer cells and modulation of surface molecules affect functional properties of CD8+ T cells. Molecular Immunology 48:15-16, pages 1744-1752.
Crossref
Margit H Lampen & Thorbald van Hall. (2011) Strategies to counteract MHC-I defects in tumors. Current Opinion in Immunology 23:2, pages 293-298.
Crossref
Alfonso Serrano, Isabel Castro-Vega & Maximino Redondo. (2011) Role of Gene Methylation in Antitumor Immune Response: Implication for Tumor Progression. Cancers 3:2, pages 1672-1690.
Crossref
Adam J. Linley, Murrium Ahmad & Robert C. Rees. (2011) Tumour-associated antigens: considerations for their use in tumour immunotherapy. International Journal of Hematology 93:3, pages 263-273.
Crossref
Milan Reiniš. (2010) Immunotherapy of MHC class I-deficient tumors. Future Oncology 6:10, pages 1577-1589.
Crossref
Xiao-Dan Yu & Z. Sheng Guo. (2010) Epigenetic drugs for cancer treatment and prevention: mechanisms of action. BioMolecular Concepts 1:3-4, pages 239-251.
Crossref
Juergen Bukur, Felix Herrmann, Diana Handke, Christian Recktenwald & Barbara Seliger. (2010) Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression. Journal of Biological Chemistry 285:40, pages 30419-30426.
Crossref
Frank A. Schildberg, Cristina A. Hagmann, Volker Böhnert & René H. Tolba. (2010) Improved transplantation outcome by epigenetic changes. Transplant Immunology 23:3, pages 104-110.
Crossref
Qing Yan. 2010. Systems Biology in Drug Discovery and Development. Systems Biology in Drug Discovery and Development 203 220 .
S Hoves, M Aigner, C Pfeiffer, M Laumer, E C Obermann & A Mackensen. (2009) In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray. Leukemia 23:5, pages 877-885.
Crossref
A. Francesca Setiadi, Kyla Omilusik, Muriel D. David, Robyn P. Seipp, Jennifer Hartikainen, Rayshad Gopaul, Kyung Bok Choi & Wilfred A. Jefferies. (2008) Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of Tumors. Cancer Research 68:23, pages 9601-9607.
Crossref
M Campoli & S Ferrone. (2008) HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance. Oncogene 27:45, pages 5869-5885.
Crossref
Iryna Saranchova, Clara Wenjing Xia, Pablo de Lucía Finkel, Lonna Munro, Cheryl G. Pfeifer & Wilfred Jefferies. (2022) A Novel Cell-Based Immunotherapy Utilizing Adoptive Transfer of Type-2 Innate Lymphoid Cells to Reduce the Growth of Tumours. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.